<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>yarndeal6</title>
    <link>//yarndeal6.bravejournal.net/</link>
    <description></description>
    <pubDate>Fri, 28 Aug 2026 00:34:00 +0000</pubDate>
    <item>
      <title>Intrathecal treatments pertaining to tuberculous meningitis: propensity-matched cohort review.</title>
      <link>//yarndeal6.bravejournal.net/intrathecal-treatments-pertaining-to-tuberculous-meningitis-propensity-matched</link>
      <description>&lt;![CDATA[htmlheadtitle502 Bad Gateway/title/head&#xD;&#xA;bodyh2502 Bad Gateway/h2h3Host Not Found or connection failed/h3/body/html&#xD;&#xA;]]&gt;</description>
      <content:encoded><![CDATA[<p>
<h2>502 Bad Gateway</h2><h3>Host Not Found or connection failed</h3></p>
]]></content:encoded>
      <guid>//yarndeal6.bravejournal.net/intrathecal-treatments-pertaining-to-tuberculous-meningitis-propensity-matched</guid>
      <pubDate>Tue, 25 Feb 2025 08:19:01 +0000</pubDate>
    </item>
    <item>
      <title>Dopaminergic Basis of Spatial Deficits during the early Parkinson&#39;s Disease.</title>
      <link>//yarndeal6.bravejournal.net/dopaminergic-basis-of-spatial-deficits-during-the-early-parkinsons-disease</link>
      <description>&lt;![CDATA[htmlheadtitle502 Bad Gateway/title/head&#xD;&#xA;bodyh2502 Bad Gateway/h2h3Host Not Found or connection failed/h3/body/html&#xD;&#xA;]]&gt;</description>
      <content:encoded><![CDATA[<p>
<h2>502 Bad Gateway</h2><h3>Host Not Found or connection failed</h3></p>
]]></content:encoded>
      <guid>//yarndeal6.bravejournal.net/dopaminergic-basis-of-spatial-deficits-during-the-early-parkinsons-disease</guid>
      <pubDate>Mon, 24 Feb 2025 08:24:01 +0000</pubDate>
    </item>
    <item>
      <title>SARS-CoV-2 Nucleocapsid Plasma Antigen with regard to Prognosis and Monitoring associated with COVID-19.</title>
      <link>//yarndeal6.bravejournal.net/sars-cov-2-nucleocapsid-plasma-antigen-with-regard-to-prognosis-and-monitoring</link>
      <description>&lt;![CDATA[Stereotactic body radiotherapy has emerged as one of the preferred treatments for patients with spine metastases, with the potential for long-term control from lesion irradiation. Post-treatment vertebral compression fractures are a known complication of this therapy, contributing to worsening pain and reduced quality of life, sometimes requiring surgical intervention. This review explores the current knowledge of post-radiotherapy fractures, in terms of the rates and associated predictive factors. A search of databases including Medline, Embase and the Cochrane Library was conducted using keywords such as &#39;vertebral compression fracture&#39;, &#39;stereotactic body radiotherapy&#39; and &#39;spine metastases&#39;. The search was limited to published studies up to March 2019, reporting clinical outcomes including both the post-treatment fracture rate and statistical identification of associated risk factors. Rates of post-treatment fractures ranged from 4 to 39%. A variety of factors were found to increase the risk, including the appearance of lytic vertebral disease, degree of pre-existing compression, spinal malalignment, increased dose per fraction and a Spinal Instability Neoplastic Score   6. CPI-0610 ic50 This knowledge can enable clinicians to counsel patients when considering management options for spine metastases, maintaining the balance between local tumour control and the risk of subsequent fracture. © 2020 The Royal Australian and New Zealand College of Radiologists.Proximal lower extremity amputations such as short transfemoral, and hip disarticulation are often required in the setting of malignancy and vascular disease.1 In the military population, the rate of traumatic proximal lower extremity amputation has increased due to increased survival from blast injury.2 These proximal levels of amputation present unique challenges, especially in suspension. Currently, total contact suction suspension systems are most commonly utilized, however, these have multiple drawbacks including discomfort, risk of skin breakdown, and often require an additional support making donning and doffing more challenging. Described are two cases in which a novel suspension system was fabricated and prescribed. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.The lack of standards to identify oligomeric molecules is a challenge for the analysis of complex organic mixtures. High-resolution mass spectrometry-specifically, FT-ICR MS-offers new opportunities for analysis of oligomers with the assignment of formulae (C x H y O z ) to detected peaks. However, matching a specific structure to a given formula remains a challenge due to the inability of FT-ICR MS to distinguish between isomers.   Additional separation techniques and other analyses (e.g. NMR) coupled with comparison of results to those from pure compounds is one route for assignment of MS peaks. Unfortunately, this strategy may be impractical for complete analysis of complex, heterogeneous samples. In this study we use computational stochastic generation of lignin oligomers to generate a molecular library for supporting the assignment of potential candidate structures to compounds detected during FT-ICR MS analysis. This approach may also be feasible for other macromolecules beyond lignin. © 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.INTRODUCTION Neo-adjuvant androgen deprivation therapy prior to radiotherapy (RT) causes shrinkage of the prostate gland, but the changes in volume have never been mapped over time in detail, nor have the associations between volume reduction and testosterone escape or prostate-specific antigen (PSA) kinetics been determined. METHODS Fifty consecutive patients with prostate cancer were treated with 6 months of triptorelin prior to definitive RT. The volume of the prostate gland was measured at the outset and every 6-7 weeks thereafter using MRI scans. The volumes were calculated using a planimetric method, and inter-rater reliability was checked. Factors associated with a large initial volume and greater reductions in it were assessed. RESULTS The median volume at the outset was 45 cc, and the median reductions every 6 weeks thereafter were 23, 18, 9 and 5%. The inter-rater agreement was high (r    0.9, P  less then  0.001). There were no baseline clinical factors associated with a high initial prostate volume, but the initial volume was associated with greater volume reduction. Testosterone escape had no effect on the reduction, and changes in volume were not reflected in PSA response kinetics. CONCLUSIONS Reductions in volume continue throughout a 6-month course of neo-adjuvant therapy but are greatest during the first 6 weeks. Although individualisation of the duration or intensity of the hormone treatment warrants further investigation, the role of prostate gland volume reduction remains uncertain. More detailed studies of tumour volume might be possible if the imaging required was acceptable and accessible to patients. © 2020 Royal Australian and New Zealand College of Radiologists.Although there has been tremendous progress in exploring new configurations of zinc-ion hybrid supercapacitors (Zn-HSCs) recently, the much lower energy density, especially the much lower areal energy density compared with that of the rechargeable battery, is still the bottleneck, which is impeding their wide applications in wearable devices. Herein, the pre-intercalation of Zn2+ which gives rise to a highly stable tunnel structure of Znx MnO2 in nanowire form that are grown on flexible carbon cloth with a disruptively large mass loading of 12 mg cm-2 is reported. More interestingly, the Znx MnO2 nanowires of tunnel structure enable an ultrahigh areal energy density and power density, when they are employed as the cathode in Zn-HSCs. The achieved areal capacitance of up to 1745.8 mF cm-2 at 2 mA cm-2 , and the remarkable areal energy density of 969.9 µWh cm-2 are comparable favorably with those of Zn-ion batteries. When integrated into a quasi-solid-state device, they also endow outstanding mechanical flexibility. The truly battery-level Zn-HSCs are timely in filling up of the battery-supercapacitor gap, and promise applications in the new generation flexible and wearable devices. © 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.]]&gt;</description>
      <content:encoded><![CDATA[<p>Stereotactic body radiotherapy has emerged as one of the preferred treatments for patients with spine metastases, with the potential for long-term control from lesion irradiation. Post-treatment vertebral compression fractures are a known complication of this therapy, contributing to worsening pain and reduced quality of life, sometimes requiring surgical intervention. This review explores the current knowledge of post-radiotherapy fractures, in terms of the rates and associated predictive factors. A search of databases including Medline, Embase and the Cochrane Library was conducted using keywords such as &#39;vertebral compression fracture&#39;, &#39;stereotactic body radiotherapy&#39; and &#39;spine metastases&#39;. The search was limited to published studies up to March 2019, reporting clinical outcomes including both the post-treatment fracture rate and statistical identification of associated risk factors. Rates of post-treatment fractures ranged from 4 to 39%. A variety of factors were found to increase the risk, including the appearance of lytic vertebral disease, degree of pre-existing compression, spinal malalignment, increased dose per fraction and a Spinal Instability Neoplastic Score &gt;6. <a href="https://www.selleckchem.com/products/cpi-0610.html">CPI-0610 ic50</a> This knowledge can enable clinicians to counsel patients when considering management options for spine metastases, maintaining the balance between local tumour control and the risk of subsequent fracture. © 2020 The Royal Australian and New Zealand College of Radiologists.Proximal lower extremity amputations such as short transfemoral, and hip disarticulation are often required in the setting of malignancy and vascular disease.1 In the military population, the rate of traumatic proximal lower extremity amputation has increased due to increased survival from blast injury.2 These proximal levels of amputation present unique challenges, especially in suspension. Currently, total contact suction suspension systems are most commonly utilized, however, these have multiple drawbacks including discomfort, risk of skin breakdown, and often require an additional support making donning and doffing more challenging. Described are two cases in which a novel suspension system was fabricated and prescribed. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.The lack of standards to identify oligomeric molecules is a challenge for the analysis of complex organic mixtures. High-resolution mass spectrometry-specifically, FT-ICR MS-offers new opportunities for analysis of oligomers with the assignment of formulae (C x H y O z ) to detected peaks. However, matching a specific structure to a given formula remains a challenge due to the inability of FT-ICR MS to distinguish between isomers.   Additional separation techniques and other analyses (e.g. NMR) coupled with comparison of results to those from pure compounds is one route for assignment of MS peaks. Unfortunately, this strategy may be impractical for complete analysis of complex, heterogeneous samples. In this study we use computational stochastic generation of lignin oligomers to generate a molecular library for supporting the assignment of potential candidate structures to compounds detected during FT-ICR MS analysis. This approach may also be feasible for other macromolecules beyond lignin. © 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.INTRODUCTION Neo-adjuvant androgen deprivation therapy prior to radiotherapy (RT) causes shrinkage of the prostate gland, but the changes in volume have never been mapped over time in detail, nor have the associations between volume reduction and testosterone escape or prostate-specific antigen (PSA) kinetics been determined. METHODS Fifty consecutive patients with prostate cancer were treated with 6 months of triptorelin prior to definitive RT. The volume of the prostate gland was measured at the outset and every 6-7 weeks thereafter using MRI scans. The volumes were calculated using a planimetric method, and inter-rater reliability was checked. Factors associated with a large initial volume and greater reductions in it were assessed. RESULTS The median volume at the outset was 45 cc, and the median reductions every 6 weeks thereafter were 23, 18, 9 and 5%. The inter-rater agreement was high (r &gt; 0.9, P  less then  0.001). There were no baseline clinical factors associated with a high initial prostate volume, but the initial volume was associated with greater volume reduction. Testosterone escape had no effect on the reduction, and changes in volume were not reflected in PSA response kinetics. CONCLUSIONS Reductions in volume continue throughout a 6-month course of neo-adjuvant therapy but are greatest during the first 6 weeks. Although individualisation of the duration or intensity of the hormone treatment warrants further investigation, the role of prostate gland volume reduction remains uncertain. More detailed studies of tumour volume might be possible if the imaging required was acceptable and accessible to patients. © 2020 Royal Australian and New Zealand College of Radiologists.Although there has been tremendous progress in exploring new configurations of zinc-ion hybrid supercapacitors (Zn-HSCs) recently, the much lower energy density, especially the much lower areal energy density compared with that of the rechargeable battery, is still the bottleneck, which is impeding their wide applications in wearable devices. Herein, the pre-intercalation of Zn2+ which gives rise to a highly stable tunnel structure of Znx MnO2 in nanowire form that are grown on flexible carbon cloth with a disruptively large mass loading of 12 mg cm-2 is reported. More interestingly, the Znx MnO2 nanowires of tunnel structure enable an ultrahigh areal energy density and power density, when they are employed as the cathode in Zn-HSCs. The achieved areal capacitance of up to 1745.8 mF cm-2 at 2 mA cm-2 , and the remarkable areal energy density of 969.9 µWh cm-2 are comparable favorably with those of Zn-ion batteries. When integrated into a quasi-solid-state device, they also endow outstanding mechanical flexibility. The truly battery-level Zn-HSCs are timely in filling up of the battery-supercapacitor gap, and promise applications in the new generation flexible and wearable devices. © 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</p>
]]></content:encoded>
      <guid>//yarndeal6.bravejournal.net/sars-cov-2-nucleocapsid-plasma-antigen-with-regard-to-prognosis-and-monitoring</guid>
      <pubDate>Sun, 23 Feb 2025 08:18:53 +0000</pubDate>
    </item>
    <item>
      <title>Your Fourier-Laplace Transform-A Conjugate Outcomes of the fabric Brain as well as the Aware Thoughts.</title>
      <link>//yarndeal6.bravejournal.net/your-fourier-laplace-transform-a-conjugate-outcomes-of-the-fabric-brain-as-well</link>
      <description>&lt;![CDATA[htmlheadtitle502 Bad Gateway/title/head&#xD;&#xA;bodyh2502 Bad Gateway/h2h3Host Not Found or connection failed/h3/body/html&#xD;&#xA;]]&gt;</description>
      <content:encoded><![CDATA[<p>
<h2>502 Bad Gateway</h2><h3>Host Not Found or connection failed</h3></p>
]]></content:encoded>
      <guid>//yarndeal6.bravejournal.net/your-fourier-laplace-transform-a-conjugate-outcomes-of-the-fabric-brain-as-well</guid>
      <pubDate>Fri, 21 Feb 2025 08:39:40 +0000</pubDate>
    </item>
    <item>
      <title>Trends throughout climatically driven severe growth cutbacks regarding Picea abies along with Pinus sylvestris within Main Europe.</title>
      <link>//yarndeal6.bravejournal.net/trends-throughout-climatically-driven-severe-growth-cutbacks-regarding-picea</link>
      <description>&lt;![CDATA[5%) in rats with streptozotocin-induced diabetes mellitus than that in control rats. This might be due to decreased absorptioncaused by the higher expression of P-glycoprotein and the faster intestinal metabolism caused by the higher expressionof intestinal CYP3A1(23), which resulted in the decreased bioavailability of tofacitinib (33.0%) in rats with streptozotocin-induceddiabetes mellitus. In summary, our findings indicate that diabetes mellitus affects the absorption and metabolism of tofacitinib,causing faster metabolism and decreased intestinal absorption in rats with streptozotocin-induced diabetes mellitus.Econazole, a potent broad-spectrum antifungal agent and a Ca2+ channel antagonist, induces cytotoxicity in leukemia cells andis used for the treatment of skin infections. However, little is known about its cytotoxic effects on solid tumor cells. Here, weinvestigated the molecular mechanism underlying econazole-induced toxicity in vitro and evaluated its regulatory effect on themetastasis of gastric cancer cells. Using the gastric cancer cell lines AGS and SNU1 expressing wild-type p53 we demonstratedthat econazole could significantly reduce cell viability and colony-forming (tumorigenesis) ability. Econazole induced G0/G1 phasearrest, promoted apoptosis, and effectively blocked proliferation- and survival-related signal transduction pathways in gastric cancercells. In addition, econazole inhibited the secretion of matrix metalloproteinase- 2 (MMP-2) and MMP-9, which degrade theextracellular matrix and basement membrane. Econazole also effectively inhibited the metastasis of gastric cancer cells, as confirmedfrom cell invasion and wound healing assays. The protein level of p53 was significantly elevated after econazole treatmentof AGS and SNU1 cells. However, apoptosis was blocked in econazole-treated cells exposed to a p53-specific small-interferingRNA (siRNA) to eliminate p53 expression. These results provide evidence that econazole could be repurposed to induce gastriccancer cell death and inhibit cancer invasion.Alzheimer&#39;s disease (AD) is associated with the accumulation and deposition of a beta-amyloid (Αβ) peptide in the brain, resulting in increased neuroinflammation and synaptic dysfunction. Intranasal delivery of targeted drugs to the brain represents a noninvasive pathway that bypasses the blood-brain barrier and minimizes systemic exposure. see more The aim of this study was to evaluate the therapeutic effect of intranasally delivered 9-cis retinoic acid (RA) on the neuropathology of an AD mouse model. Herein, we observed dramatically decreased Αβ deposition in the brains of amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic mice (APP/PS1) treated intranasally with 9-cis RA for 4 weeks compared to that in the brains of vehicle-treated mice. Importantly, intranasal delivery of 9-cis RA suppressed Αβ-associated astrocyte activation and neuroinflammation and ultimately restored synaptic deficits in APP/PS1 transgenic mice. These results support the critical roles of Αβ-associated neuroinflammation responses to synaptic deficits, particularly during the deposition of Αβ. Our findings provide strong evidence that intranasally delivered 9-cis RA attenuates neuronal dysfunction in an AD mouse model and is a promising therapeutic strategy for the prevention and treatment of AD.TET family members (TETs) encode proteins that represent crucial factors in the active DNA demethylation pathway. Evidence has proved that TET2 mutation is associated with leukemogenesis, drug response, and prognosis in acute myeloid leukemia (AML). However, few studies revealed the TETs expression and its clinical significance in AML. We conducted a detailed expression and prognosis analysis of TETs expression in human AML cell lines and patients by using public databases. We observed that TETs expression especially TET2 and TET3 was closely associated with AML among various human cancers. TET1 expression was significantly reduced in AML patients, whereas TET2 and TET3 expression was significantly increased. Kaplan-Meier analysis showed that only TET3 expression was associated with overall survival (OS) and disease-free survival (DFS) among both total AML as well as non-M3 AML, and was confirmed by another independent cohort. Moreover, Cox regression analysis revealed that TET3 expression may act as an independent prognostic factor for OS and DFS in total AML. Interestingly, patients that received hematopoietic stem cell transplantation (HSCT) did not show significantly longer OS and DFS than those who did not receive HSCT in TET3 high-expressed groups; whereas, in TET3 low-expressed groups, patients that accepted HSCT showed significantly longer OS and DFS than those who did not accept HSCT. By bioinformatics analysis, TET3 expression was found positively correlated with tumor suppressor gene including CDKN2B, ZIC2, miR-196a, and negatively correlated with oncogenes such as PAX2 and IL2RA. Our study demonstrated that TETs showed significant expression differences in AML, and TET3 expression acted as a potential prognostic biomarker in AML, which may guide treatment choice between chemotherapy and HSCT.Long noncoding RNAs (lncRNAs) play critical roles in tumour progression and metastasis. Emerging evidence indicates that the lncRNA X inactive-specific transcript (XIST) is dysregulated in several tumor types, including non-small cell lung cancer (NSCLC). However, in NSCLC and other cancers the oncogenic mechanism of XIST remains incompletely understood. Here, we confirmed that XIST is upregulated in human NSCLC specimens, and is especially overexpressed in tumors previously treated with cisplatin (cis-diamminedichloroplatinum(II); DDP). In vitro, XIST knockdown inhibited NSCLC cell growth and promoted DDP chemosensitivity by stimulating apoptosis and pyroptosis. Moreover, XIST&#39;s oncogenic effects and ability to promote DDP chemoresistance were largely related to its binding to the TGF-β effector SMAD2, which inhibited its translocation to the nucleus and prevented the transcription of p53 and NLRP3, crucial regulators of apoptosis and pyroptosis, respectively. Using DDP-resistant NSCLC cells, mouse xenograft studies verified the oncogenic function of XIST and its ability to inhibit programmed cell death, thereby mediating DDP chemoresistance.]]&gt;</description>
      <content:encoded><![CDATA[<p>5%) in rats with streptozotocin-induced diabetes mellitus than that in control rats. This might be due to decreased absorptioncaused by the higher expression of P-glycoprotein and the faster intestinal metabolism caused by the higher expressionof intestinal CYP3A1(23), which resulted in the decreased bioavailability of tofacitinib (33.0%) in rats with streptozotocin-induceddiabetes mellitus. In summary, our findings indicate that diabetes mellitus affects the absorption and metabolism of tofacitinib,causing faster metabolism and decreased intestinal absorption in rats with streptozotocin-induced diabetes mellitus.Econazole, a potent broad-spectrum antifungal agent and a Ca2+ channel antagonist, induces cytotoxicity in leukemia cells andis used for the treatment of skin infections. However, little is known about its cytotoxic effects on solid tumor cells. Here, weinvestigated the molecular mechanism underlying econazole-induced toxicity in vitro and evaluated its regulatory effect on themetastasis of gastric cancer cells. Using the gastric cancer cell lines AGS and SNU1 expressing wild-type p53 we demonstratedthat econazole could significantly reduce cell viability and colony-forming (tumorigenesis) ability. Econazole induced G0/G1 phasearrest, promoted apoptosis, and effectively blocked proliferation- and survival-related signal transduction pathways in gastric cancercells. In addition, econazole inhibited the secretion of matrix metalloproteinase- 2 (MMP-2) and MMP-9, which degrade theextracellular matrix and basement membrane. Econazole also effectively inhibited the metastasis of gastric cancer cells, as confirmedfrom cell invasion and wound healing assays. The protein level of p53 was significantly elevated after econazole treatmentof AGS and SNU1 cells. However, apoptosis was blocked in econazole-treated cells exposed to a p53-specific small-interferingRNA (siRNA) to eliminate p53 expression. These results provide evidence that econazole could be repurposed to induce gastriccancer cell death and inhibit cancer invasion.Alzheimer&#39;s disease (AD) is associated with the accumulation and deposition of a beta-amyloid (Αβ) peptide in the brain, resulting in increased neuroinflammation and synaptic dysfunction. Intranasal delivery of targeted drugs to the brain represents a noninvasive pathway that bypasses the blood-brain barrier and minimizes systemic exposure. <a href="https://www.selleckchem.com/products/azd5582.html">see more</a> The aim of this study was to evaluate the therapeutic effect of intranasally delivered 9-cis retinoic acid (RA) on the neuropathology of an AD mouse model. Herein, we observed dramatically decreased Αβ deposition in the brains of amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic mice (APP/PS1) treated intranasally with 9-cis RA for 4 weeks compared to that in the brains of vehicle-treated mice. Importantly, intranasal delivery of 9-cis RA suppressed Αβ-associated astrocyte activation and neuroinflammation and ultimately restored synaptic deficits in APP/PS1 transgenic mice. These results support the critical roles of Αβ-associated neuroinflammation responses to synaptic deficits, particularly during the deposition of Αβ. Our findings provide strong evidence that intranasally delivered 9-cis RA attenuates neuronal dysfunction in an AD mouse model and is a promising therapeutic strategy for the prevention and treatment of AD.TET family members (TETs) encode proteins that represent crucial factors in the active DNA demethylation pathway. Evidence has proved that TET2 mutation is associated with leukemogenesis, drug response, and prognosis in acute myeloid leukemia (AML). However, few studies revealed the TETs expression and its clinical significance in AML. We conducted a detailed expression and prognosis analysis of TETs expression in human AML cell lines and patients by using public databases. We observed that TETs expression especially TET2 and TET3 was closely associated with AML among various human cancers. TET1 expression was significantly reduced in AML patients, whereas TET2 and TET3 expression was significantly increased. Kaplan-Meier analysis showed that only TET3 expression was associated with overall survival (OS) and disease-free survival (DFS) among both total AML as well as non-M3 AML, and was confirmed by another independent cohort. Moreover, Cox regression analysis revealed that TET3 expression may act as an independent prognostic factor for OS and DFS in total AML. Interestingly, patients that received hematopoietic stem cell transplantation (HSCT) did not show significantly longer OS and DFS than those who did not receive HSCT in TET3 high-expressed groups; whereas, in TET3 low-expressed groups, patients that accepted HSCT showed significantly longer OS and DFS than those who did not accept HSCT. By bioinformatics analysis, TET3 expression was found positively correlated with tumor suppressor gene including CDKN2B, ZIC2, miR-196a, and negatively correlated with oncogenes such as PAX2 and IL2RA. Our study demonstrated that TETs showed significant expression differences in AML, and TET3 expression acted as a potential prognostic biomarker in AML, which may guide treatment choice between chemotherapy and HSCT.Long noncoding RNAs (lncRNAs) play critical roles in tumour progression and metastasis. Emerging evidence indicates that the lncRNA X inactive-specific transcript (XIST) is dysregulated in several tumor types, including non-small cell lung cancer (NSCLC). However, in NSCLC and other cancers the oncogenic mechanism of XIST remains incompletely understood. Here, we confirmed that XIST is upregulated in human NSCLC specimens, and is especially overexpressed in tumors previously treated with cisplatin (cis-diamminedichloroplatinum(II); DDP). In vitro, XIST knockdown inhibited NSCLC cell growth and promoted DDP chemosensitivity by stimulating apoptosis and pyroptosis. Moreover, XIST&#39;s oncogenic effects and ability to promote DDP chemoresistance were largely related to its binding to the TGF-β effector SMAD2, which inhibited its translocation to the nucleus and prevented the transcription of p53 and NLRP3, crucial regulators of apoptosis and pyroptosis, respectively. Using DDP-resistant NSCLC cells, mouse xenograft studies verified the oncogenic function of XIST and its ability to inhibit programmed cell death, thereby mediating DDP chemoresistance.</p>
]]></content:encoded>
      <guid>//yarndeal6.bravejournal.net/trends-throughout-climatically-driven-severe-growth-cutbacks-regarding-picea</guid>
      <pubDate>Thu, 20 Feb 2025 08:16:35 +0000</pubDate>
    </item>
    <item>
      <title>Quorum Sensing Pseudomonas Quinolone Transmission Types Chiral Supramolecular Devices Together with the Number Safeguard Peptide LL-37.</title>
      <link>//yarndeal6.bravejournal.net/quorum-sensing-pseudomonas-quinolone-transmission-types-chiral-supramolecular</link>
      <description>&lt;![CDATA[htmlheadtitle502 Bad Gateway/title/head&#xD;&#xA;bodyh2502 Bad Gateway/h2h3Host Not Found or connection failed/h3/body/html&#xD;&#xA;]]&gt;</description>
      <content:encoded><![CDATA[<p>
<h2>502 Bad Gateway</h2><h3>Host Not Found or connection failed</h3></p>
]]></content:encoded>
      <guid>//yarndeal6.bravejournal.net/quorum-sensing-pseudomonas-quinolone-transmission-types-chiral-supramolecular</guid>
      <pubDate>Wed, 19 Feb 2025 17:29:02 +0000</pubDate>
    </item>
  </channel>
</rss>